to large quantity of unfulfilled sales orders placed by customers before year end and anticipated orders at the next year beginning, which is in line with the increased scale of sales during the year. Working capital was $17.4 million, compared with $10.0 million at the end of 2009. As of December 31, 2010, the Company had $2.0 million in short-term debt. Stockholders' equity totaled $17.6 million as of December 31, 2010, compared with $10.3 million at the end of 2009. For the year ended December 31, 2010, Global Pharm generated $8.9 million cash from operating activities, as compared to $10.2 million for 2009. The Company used $12.1 million in cash for financing activities for the twelve months ended December 31, 2010 compared with $7.8 million for the twelve months ended December 31, 2009, mainly due to dividends paid to the former stockholders of the Company's operating subsidiaries. The diluted weighted average number of shares outstanding was 21.8 million as of December 31, 2010.

Business OutlookMr. Yin concluded, "We believe that the National Health Program will further drive the reform and consolidation of China's pharmaceutical industry in the next several years. This consolidation will bring historical opportunities for Global Pharm to acquire more distribution units to underline perspective sustainable growth. In 2011, we will focus on a series of acquisition of several targeting pioneer city-level distributors to build a solid comprehensive sale network in Shandong Province. We believe the formation of this broad local distribution network will smooth a pipeline between the pharmaceutical manufacturers and distributors, as well as to effectively alleviate incumbent multiple layers in the distribution channel and lower the price mark-up for pharmaceuticals. Moreover, the growing distribution channels will help us to create a significant competitive edge in the market by getting more preferential price and products from numerous prestigious domes'/>"/>

(Date:7/31/2015)... ... 31, 2015 , ... Global Resorcinol Market 2015-2019 is a ... the global resorcinol industry. The report highlights the various growth prospects and the ... analysis of primary and secondary inputs from the existing players of the resorcinol ...

(Date:7/30/2015)... 2015 GenoSpace , a leading provider ... analysis of genomic and other biomedical data, today ... the company as Vice President of Sales and ... "GenoSpace partners with its customers ... and explore complex sets of genomic, phenotypic and ...

(Date:7/30/2015)... , July 30, 2015 Discovery Laboratories, ... it has received the second $1.0M tranche under ... Research (SBIR) grant valued at up to $3.0 ... aerosolized KL4 surfactant as a potential medical countermeasure ... Discovery Labs was awarded an initial $1.0 million ...

... UPPSALA, Sweden, October 5 , ... - At One Sixth the Price of QuanTyper(TM) Without Loss of ... Rapidly Penetrate the Market , AlphaHelix (Ticker: ... AmpXpress(TM) - to meet demands for lower,instrument prices. This was made ...

... Inc. (Nasdaq: ONTY ) (TSX: ONY) today announced ... Officer of ZymoGenetics, Inc. (Nasdaq: ZGEN), to its board ... to our board of directors and look forward to ... experience in drug development, research and operations will be ...

... , BASKING RIDGE, N.J., Oct. 5 Regado Biosciences, ... aptamers with active control agents, announced today that David ... be presenting at the Japan Biopharma Conference 2009 at ... presentation is scheduled for 2:40pm (GMT +9:00) on October ...

(Date:7/7/2015)... , July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... the growing mobile commerce market announces a revised version of one ... The commercial will air on CNBC in New York ... and San Francisco metro areas. ... focuses on Wocket,s ability to replace all the cards in your ...

(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...

... at the University of Pittsburgh School of Medicine and ... drug that their research indicates holds great promise for ... 105 participants will be randomly assigned to receive either ... for osteoporosis treatment, or an experimental agent called parathyroid ...

... KNOXVILLE -- It,s not thinking in the way humans, dogs ... the University of Tennessee, Knoxville, show that bacteria are more ... sets a landmark in research to understand the way bacteria ... environment, a trait shared by nearly all living things, and ...

... each year on exotic smelling perfumes and lotions in the ... study in Psychological Science , a journal of the ... best way to capture a potential mate,s attention. Smells ... studies have shown that male testosterone levels are influenced by ...

... carriers to suit the widest possible range ... science laboratory. Labware carriers can be placed ... is simple for the user, thanks to ... are correctly guided into position. This allows ...

... is a new tuning and calibration standard ... spectrometry. Accumix is a lyophilized 7-peptide ... for both tuning and calibration of ion ... Fourier transform mass spectrometers. Direct infusion ...